Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 434 of 6351
-
AI blood test could catch lung cancer early in smokers with COPD
Diagnosis Recruiting nowThe study is a prospective, non-randomized feasibility study evaluating blood sample and machine learning-based risk stratification for lung cancer in patients with COPD (chronic obstructive pulmonary disease). Patients with COPD will be recruited in general practice, where they…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Can leishmania antigens trigger a protective immune response?
Knowledge-focused Recruiting nowThis study assesses the immunoprevalence (presence of the induced T-cell response across different patients (and thus HLA types) of six prioritized IPX-derived Leishmania antigens, using Good Laboratory Practice-grade soluble Leishmania antigen (GLP-SLA) as a positive control. Lo…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Blood test could revolutionize Alzheimer's diagnosis at your Doctor's office
Diagnosis Recruiting nowThe goal of this study is to determine how blood biomarker tests (ptau217 and ptau217/Aβ42) performed in primary care influence the patient trajectory in individuals with cognitive concerns. Participants will provide a blood sample for biomarker testing and undergo clinical asse…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 14:03 UTC
-
Gene therapy injection targets Parkinson's in patients with GBA1 mutations
Disease control Not yet recruitingA Phase I/II Clinical Study to Evaluate the Tolerability, Safety, and Efficacy of VGN-R08b Intra-cerebroventricular injection in Parkinson's Disease Patients with GBA1 Mutations
Phase 1/2 • Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug could reduce Blood-Letting for polycythemia vera patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of sapablursen when added on to current standard of care (SOC) for Polycythemia Vera (PV) therapy. The study will be conducted in three sequential parts (Part 1a blinded treatment, Part 1b open-label treatment, \& P…
Phase 3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a simple STI test prevent preterm birth?
Prevention Recruiting nowThis study will evaluate whether routine screening and treatment for two common sexually transmitted infections, chlamydia and gonorrhoea, during pregnancy can reduce preterm birth and other poor birth outcomes in Botswana, and whether this approach is affordable and cost-effecti…
Sponsor: Adriane Wynn • Aim: Prevention
Last updated Jul 04, 2026 00:00 UTC
-
New drug duo targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis is an open-label, multicenter Phase II clinical study conducted in subjects with advanced breast cancer.
Phase 2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Lupus drug trial aims for remission without daily pills
Disease control Recruiting nowThis study will assess how mosunetuzumab works in people who have systemic lupus erythematosus (SLE) who may or may not also have active lupus nephritis (LN).
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Freeze-and-Heat attack: could a new device boost liver cancer treatment?
Disease control Not yet recruitingMultimodal Thermal Therapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone for systemically untreated unresectable hepatocellular carcinoma (HCC)
Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New enzyme shot takes aim at Hard-to-Treat tumors
Disease control Recruiting nowThe goal of this clinical trial is to learn if N17350 works to treat advanced solid tumors in adults. It will also learn about the safety of N17350 and help determine the best dose to use in future studies. The main questions it aims to answer are: 1. Does N17350 cause tumors t…
Phase 1/2 • Sponsor: Onchilles Pharma Inc • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
AI reads chest X-Rays in the ER to catch silent killers early
Diagnosis Recruiting nowSEARCH-ED is a research study which is running in Emergency Department (ED) of the Queen Elizabeth University Hospital. The aim of the study is to find out if using a computer programme can help doctors diagnose heart and lung problems from chest x-rays. We want to compare how m…
Sponsor: NHS Greater Glasgow and Clyde • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Herbal tablet aims to reverse liver scarring in fatty liver disease
Disease control Not yet recruitingThis is a multicenter, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Fuzheng Huayu Tablets in patients with metabolic dysfunction-associated fatty liver cirrhosis (compensated). Eligible patients will be randomly assigned to re…
Phase 4 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a simple swab predict who needs less radiation?
Diagnosis Recruiting nowThis study focuses on the longitudinal monitoring of HPV infection in patients with head and neck cancers, particularly oropharyngeal carcinoma (OPC), using a new electrochemical detection method. This method has already been successfully developed and validated for cervical canc…
Sponsor: Masaryk Memorial Cancer Institute • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Texting for health: could a simple WhatsApp nudge boost HIV protection?
Prevention Recruiting nowThis study will create and follow an online cohort of sexual and gender minorities in Brazil to better understand the use of HIV prevention and treatment strategies, particularly pre-exposure prophylaxis (PrEP) and antiretroviral treatment (ART). Participants will complete online…
Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Heart valve fix without a surgery center? major trial tests safety
Disease control Recruiting nowTRACS-PRIME is a prospective, randomized, multicenter clinical trial evaluating whether transcatheter aortic valve implantation (TAVI) can be performed safely and effectively in selected hospitals without on-site cardiac surgery, when appropriate patient selection, experienced op…
Sponsor: University Hospital of Ferrara • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Lupus patients may get new hope from In-Body cell therapy
Disease control Recruiting nowThis is a single-center, open-label, exploratory clinical study designed to evaluate the efficacy and safety of IASO207 Injection (in vivo CAR-T) in patients with active refractory systemic lupus erythematosus.
Early phase 1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Acupuncture with a jolt: could needles shield nerves from chemo?
Prevention Not yet recruitingThis randomized controlled clinical trial aims to clarify the clinical efficacy and safety of electroacupuncture combined with thumbtack needle for the prevention of chemotherapy-induced peripheral neuropathy(CIPN), and to provide high-level evidence-based medicine for the preven…
Sponsor: Affiliated Hospital of Qinghai University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
New 24-Strain pneumonia vaccine enters human trials
Vaccine Recruiting nowThis clinical trial consists of Phase I and Phase II. The objective is to evaluate the safety and immunogenicity of the 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxoid) in individuals aged 2 months (minimum 6 weeks) and older.
Phase 1/2 • Sponsor: CanSino Biologics Inc. • Aim: Vaccine
Last updated Aug 07, 2026 00:00 UTC
-
Magic mushroom therapy could ease PTSD in sexual assault survivors
Symptom relief Recruiting nowA Phase 2, Open-Label Study to explore the efficacy, safety, and tolerability of psilocybin-assisted therapy in women with sexual assault-related Posttraumatic Stress Disorder (PTSD).
Phase 2 • Sponsor: Sunstone Medical • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New hope for ulcerative colitis: experimental drug JNJ-78934804 enters final testing phase
Disease control Recruiting nowThe purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining o…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC